BioDelivery Sciences Announces Upcoming Investor Conference Presentations
May 29 2019 - 4:10PM
BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a
rapidly growing commercial-stage specialty pharmaceutical company
dedicated to patients living with chronic conditions today
announced that Herm Cukier, Chief Executive Officer will present at
the following investor conferences:
- Jefferies 2019 Healthcare Conference on Tuesday, June 4, 2019,
at 4:00 PM ET
- William Blair 39th Annual Growth Stock Conference on Wednesday,
June 5, 2019, at 10:40 AM CT
The sessions may be accessed from the "Investors" page of
BDSI’s website at https://bdsi.com. Replays of the
presentation will be archived on the Company's website and made
available for 60 days.
ABOUT BIODELIVERY SCIENCES INTERNATIONAL,
INC.
BioDelivery Sciences International,
Inc. (NASDAQ: BDSI) is a commercial-stage specialty
pharmaceutical company dedicated to patients living with chronic
conditions. BDSI has built a portfolio of products that includes
utilizing its novel and proprietary BioErodible MucoAdhesive
(BEMA®) technology to develop and commercialize, either on its own
or in partnership with third parties, new applications of proven
therapies aimed at addressing important unmet medical needs. BDSI's
marketed products and those in development address serious and
debilitating conditions such as chronic pain, breakthrough cancer
pain, opioid dependence, and opioid-induced constipation.
Contact:
Mary ColemanVice President, Investor Relations and Corporate
CommunicationsBioDelivery Sciences International,
Inc.mcoleman@bdsi.com
BioDelivery Sciences (NASDAQ:BDSI)
Historical Stock Chart
From Aug 2024 to Sep 2024
BioDelivery Sciences (NASDAQ:BDSI)
Historical Stock Chart
From Sep 2023 to Sep 2024